The headaches may indicate early vascular dysfunction, suggesting that some adolescents could face cardiovascular risk years before symptoms typically emerge in adults.

Israel’s BioLight Life Sciences has completed a successful US clinical study designed to assess the effectiveness of a test evaluating tears’ components of patients suffering from dry eye syndrome, and Israeli startup SoniVie has a novel system for the treatment of pulmonary arterial hypertension.